Therapeutic Advances in Neurological Disorders (Jan 2016)

A comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain–Barré syndrome in Upper Egypt

  • Khaled Saad,
  • Ismail L. Mohamad,
  • Mohamed A. Abd El-Hamed,
  • Mostafa S K Tawfeek,
  • Ahmed E. Ahmed,
  • Khaled A. Abdel Baseer,
  • Ahmed S. El-Shemy,
  • Amira A. El-Houfey,
  • Diaa M. Tamer

DOI
https://doi.org/10.1177/1756285615610471
Journal volume & issue
Vol. 9

Abstract

Read online

Objective: The aim of our study is to assess the clinico-electrophysiological profile of children with Guillain–Barré syndrome (GBS) in Upper Egypt and to compare the efficacy of plasmapheresis versus other treatment modalities. Patients and methods: This was a retrospective study of children from January 2010 to October 2014 diagnosed as GBS. It included 62 cases. Results: Acute inflammatory demyelinating polyradiculoneuropathy (AIDP) was the most prevalent type of GBS in our locality. As regards the treatment, 32 cases received plasmapheresis while 30 patients received intravenous immunoglobulin. We found a significant decrease in the duration of hospitalization and a significant increase in the number of children with complete recovery in cases treated with plasmapheresis. Conclusion: GBS is not uncommon in children of Upper Egypt, with AIDP the most prevalent type. Plasmapheresis is the best treatment modalities for GBS as it reduces the duration of hospital stay and hastens the recovery of those children.